calendar
14,264 catalysts · 13,680 approval · 5,000 device 510k · 4,728 grant · 3,183 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
14,264 catalysts · 13,680 approval · 5,000 device 510k · 4,728 grant · 3,183 8k filing · 2,000 device pma · 2,000 device recall
no tagged catalysts yet
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL
Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL
Sponsor: UNIQUE. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION
Sponsor: IMPAX LABS. Form: TABLET. Route: ORAL
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: ENDO OPERATIONS. Form: TABLET. Route: ORAL
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: AUROBINDO PHARMA USA. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: ABBVIE INC. Form: VIAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: RILEY CONSUMER. Form: CAPSULE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GRANULES INDIA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL